HHS Selects 15 New Drugs for Medicare Part D Price Negotiations
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices expected to take effect in 2027.
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic
Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities, federal health officials announced in a news release. The negotiations,
Medicare targets 15 more drugs for price negotiations — including Ozempic
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
Trump Reverses Some Biden Drug Pricing Initiatives, Potentially Impacting Medicare Costs
Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
Trump rolls back effort to lower Medicare, Medicaid drug costs
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
Trump cancels Biden’s rule to help Medicare lower prescription drug prices
Drug pricing experts are not sure why rolling back drug pricing initiatives would be a day one priority for President Trump.
Lawmakers oppose Trump’s reversal on Medicare drug prices
Concern is growing among Democrats after President Donald Trump reversed some of the former president’s executive orders, including efforts to reduce prescription drug costs for Medicare and
Benefits Pro2h
Trump administration pauses most CDC, HHS and CMS communications
The exact scope and duration is clear, and one question is what will happen to release of CDC data that employers and insurers use in pricing.
Modern Healthcare1d
Trump freezes HHS communications
The Health and Human Services Department won’t issue health advisories, reports or other materials until further notice, with ...
HHS Secretary Becerra urges Trump administration to 'continue to grow' the ACA
As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...
STAT9d
Former Trump White House, HHS aide Abe Sutton likely to lead Medicare, Medicaid innovation center
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
Yes, Trump rescinded Biden's order to lower prescription drug costs for people on Medicare and Medicaid
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
Departed Biden Medicare Chief Lauds Landmark Drug Negotiations
Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...
MM&M6d
Ozempic and Wegovy make the list of the next 15 drugs in Medicare negotiations: HHS
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
Skilled Nursing News20h
Legal Defeat Remains Key Even if Legislative, Administrative Barriers Make Repeal of the Nursing Home Staffing Mandate Inevitable
In the aftermath of the Department of Health and Human Services’ (HHS) response to a pending lawsuit against the federal ...